Daniel Jones - Concepedia

Author

Daniel Jones

Also Known As

D Jones, D R Jones, D. Jones, D. R. Jones, D.R. Jones, Daniel JONES, Daniel Jones, Daniel R Jones, Daniel R. Jones, David Lanier Jones

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

The Ohio State University Indiana Wesleyan University Georgetown University Dana-Farber Cancer Institute

About

Daniel Jones is an author at The Ohio State University specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	675
2	Cell Biology	2	2	80
3	Health Sciences	1	1	102
4	Public Health	1	1	20
5	Epidemiology	1	1	20

Daniel Jones

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
<i>BTK</i><sup>C481S</sup>-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia Jennifer A. Woyach, Amy S. Ruppert, Daphne Guinn, Journal of Clinical Oncology Hematological MalignancyChronic Lymphocytic LeukemiaBruton Tyrosine KinaseMedicineMixed-phenotype Acute Leukemia	2017	461
A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype Wyndham H. Wilson, Sin‐Ho Jung, Pierluigi Porcu, Haematologica	2011	165
Analysis of genetic and phenotypic heterogeneity in juvenile polyposis K Woodford-Richens, Steve Bevan, Michael Churchman, Gut	2000	134
Phase II study of acalabrutinib in ibrutinib-intolerant patients with relapsed/refractory chronic lymphocytic leukemia Kerry A. Rogers, Philip A. Thompson, John N. Allan, Haematologica ImmunologyPathologyPhase Ii StudyPharmacotherapyImmunotherapy	2021	102
Estrogen receptor-mediated repression of human hepatic lipase gene transcription Daniel Jones, Robert J. Schmidt, Richard T. Pickard, Journal of Lipid Research	2002	91
PLCG2 C2 domain mutations co-occur with BTK and PLCG2 resistance mutations in chronic lymphocytic leukemia undergoing ibrutinib treatment Daniel Jones, Jennifer A. Woyach, Weiqiang Zhao, Leukemia Hematological MalignancyLymphoid NeoplasiaChronic Lymphocytic LeukemiaPlcg2 Resistance MutationsHematology	2017	67
Nmp4/CIZ regulation of <i>matrix metalloproteinase 13</i> (<i>MMP-13</i>) response to parathyroid hormone in osteoblasts Rita Shah, Marta Alvarez, Daniel Jones, American Journal of Physiology-Endocrinology and Metabolism	2004	43
Assessment of British Gammaglobulin in Preventing Infectious Hepatitis Yvonne E. Cossart, Elizabeth Gillespie, Daniel Jones, BMJ VaccinationIncubation PeriodInfectious Disease PreventionPreventive MedicineHepatology	1968	20
Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation Evan C. Chen, Shuli Li, Ann-Kathrin Eisfeld, Transplantation and Cellular Therapy	2021	18
A potential osteoporosis target in the FAS ligand/FAS pathway of osteoblast to osteoclast signaling. Daniel Jones PubMed SclerostinImmune RegulationImmunologyMolecular BiologyImmune System	2015	13

Page 1